Effectiveness of clarithromycin in patients with yellow nail syndrome

Abstract Background Yellow nail syndrome (YNS) is a rare disease characterized by the triad of thickened, slow-growing yellow nails, lymphedema, and chronic respiratory manifestations. The cause of YNS is not known; however, it is suggested to be due to a congenital lymph abnormality. Since YNS is a...

Full description

Bibliographic Details
Main Authors: Sachi Matsubayashi, Manabu Suzuki, Tomoyuki Suzuki, Ayako Shiozawa, Konomi Kobayashi, Satoru Ishii, Motoyasu Iikura, Shinyu Izumi, Koichiro Kudo, Haruhito Sugiyama
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12890-018-0707-4
_version_ 1818765890366210048
author Sachi Matsubayashi
Manabu Suzuki
Tomoyuki Suzuki
Ayako Shiozawa
Konomi Kobayashi
Satoru Ishii
Motoyasu Iikura
Shinyu Izumi
Koichiro Kudo
Haruhito Sugiyama
author_facet Sachi Matsubayashi
Manabu Suzuki
Tomoyuki Suzuki
Ayako Shiozawa
Konomi Kobayashi
Satoru Ishii
Motoyasu Iikura
Shinyu Izumi
Koichiro Kudo
Haruhito Sugiyama
author_sort Sachi Matsubayashi
collection DOAJ
description Abstract Background Yellow nail syndrome (YNS) is a rare disease characterized by the triad of thickened, slow-growing yellow nails, lymphedema, and chronic respiratory manifestations. The cause of YNS is not known; however, it is suggested to be due to a congenital lymph abnormality. Since YNS is accompanied by chronic bronchial infection in more than half of patients, we hypothesized that treatment with clarithromycin (CAM) could be effective. We therefore evaluated the effectiveness of CAM against nail discoloration and respiratory manifestation in patients with YNS. Methods We conducted an observational study involving 5 patients with YNS who were treated at our institution between January 2005 and January 2016. CAM was prescribed for every patient. Patient demographic information, comorbidities, medications, chest radiographs, and clinical data such as nail color were extracted to evaluate clinical outcome. Results Mean patient age was 71.6 years, and 2 patients (40%) were male. Four patients had sinusitis, and 2 had rheumatoid arthritis. Regarding respiratory manifestations, 4 patients had sinobronchial syndrome and 2 had pleural effusion. Nail discoloration improved in every patient after CAM treatment. Four patients also experienced improvement in their respiratory manifestations. Conclusions In patients with YNS, the anti-inflammatory activity of macrolides might improve their systemic inflammation. This improvement could help to reduce lymphedema and promote nail growth. Trial registration Ethical approval was provided by the institutional review board of the National Center of Global Health and Medicine (NCGM-G-002143-00), in January 2017. This study is retrospectively registered for UMIN Clinical Trial Registry (UMIN000028514) in August 4th, 2017.
first_indexed 2024-12-18T08:25:17Z
format Article
id doaj.art-a3b4b40fe08a47a4a701c119286e64df
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-12-18T08:25:17Z
publishDate 2018-08-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-a3b4b40fe08a47a4a701c119286e64df2022-12-21T21:14:38ZengBMCBMC Pulmonary Medicine1471-24662018-08-011811610.1186/s12890-018-0707-4Effectiveness of clarithromycin in patients with yellow nail syndromeSachi Matsubayashi0Manabu Suzuki1Tomoyuki Suzuki2Ayako Shiozawa3Konomi Kobayashi4Satoru Ishii5Motoyasu Iikura6Shinyu Izumi7Koichiro Kudo8Haruhito Sugiyama9Department of Respiratory Medicine, National Center for Global Health and MedicineDepartment of Respiratory Medicine, National Center for Global Health and MedicineDepartment of Respiratory Medicine, National Center for Global Health and MedicineDepartment of Respiratory Medicine, National Center for Global Health and MedicineDepartment of Respiratory Medicine, National Center for Global Health and MedicineDepartment of Respiratory Medicine, National Center for Global Health and MedicineDepartment of Respiratory Medicine, National Center for Global Health and MedicineDepartment of Respiratory Medicine, National Center for Global Health and MedicineWaseda University Organization for Regional and Inter-regional StudiesDepartment of Respiratory Medicine, National Center for Global Health and MedicineAbstract Background Yellow nail syndrome (YNS) is a rare disease characterized by the triad of thickened, slow-growing yellow nails, lymphedema, and chronic respiratory manifestations. The cause of YNS is not known; however, it is suggested to be due to a congenital lymph abnormality. Since YNS is accompanied by chronic bronchial infection in more than half of patients, we hypothesized that treatment with clarithromycin (CAM) could be effective. We therefore evaluated the effectiveness of CAM against nail discoloration and respiratory manifestation in patients with YNS. Methods We conducted an observational study involving 5 patients with YNS who were treated at our institution between January 2005 and January 2016. CAM was prescribed for every patient. Patient demographic information, comorbidities, medications, chest radiographs, and clinical data such as nail color were extracted to evaluate clinical outcome. Results Mean patient age was 71.6 years, and 2 patients (40%) were male. Four patients had sinusitis, and 2 had rheumatoid arthritis. Regarding respiratory manifestations, 4 patients had sinobronchial syndrome and 2 had pleural effusion. Nail discoloration improved in every patient after CAM treatment. Four patients also experienced improvement in their respiratory manifestations. Conclusions In patients with YNS, the anti-inflammatory activity of macrolides might improve their systemic inflammation. This improvement could help to reduce lymphedema and promote nail growth. Trial registration Ethical approval was provided by the institutional review board of the National Center of Global Health and Medicine (NCGM-G-002143-00), in January 2017. This study is retrospectively registered for UMIN Clinical Trial Registry (UMIN000028514) in August 4th, 2017.http://link.springer.com/article/10.1186/s12890-018-0707-4BronchiectasisClarithromycinSigns and symptoms, respiratoryYellow nail syndrome
spellingShingle Sachi Matsubayashi
Manabu Suzuki
Tomoyuki Suzuki
Ayako Shiozawa
Konomi Kobayashi
Satoru Ishii
Motoyasu Iikura
Shinyu Izumi
Koichiro Kudo
Haruhito Sugiyama
Effectiveness of clarithromycin in patients with yellow nail syndrome
BMC Pulmonary Medicine
Bronchiectasis
Clarithromycin
Signs and symptoms, respiratory
Yellow nail syndrome
title Effectiveness of clarithromycin in patients with yellow nail syndrome
title_full Effectiveness of clarithromycin in patients with yellow nail syndrome
title_fullStr Effectiveness of clarithromycin in patients with yellow nail syndrome
title_full_unstemmed Effectiveness of clarithromycin in patients with yellow nail syndrome
title_short Effectiveness of clarithromycin in patients with yellow nail syndrome
title_sort effectiveness of clarithromycin in patients with yellow nail syndrome
topic Bronchiectasis
Clarithromycin
Signs and symptoms, respiratory
Yellow nail syndrome
url http://link.springer.com/article/10.1186/s12890-018-0707-4
work_keys_str_mv AT sachimatsubayashi effectivenessofclarithromycininpatientswithyellownailsyndrome
AT manabusuzuki effectivenessofclarithromycininpatientswithyellownailsyndrome
AT tomoyukisuzuki effectivenessofclarithromycininpatientswithyellownailsyndrome
AT ayakoshiozawa effectivenessofclarithromycininpatientswithyellownailsyndrome
AT konomikobayashi effectivenessofclarithromycininpatientswithyellownailsyndrome
AT satoruishii effectivenessofclarithromycininpatientswithyellownailsyndrome
AT motoyasuiikura effectivenessofclarithromycininpatientswithyellownailsyndrome
AT shinyuizumi effectivenessofclarithromycininpatientswithyellownailsyndrome
AT koichirokudo effectivenessofclarithromycininpatientswithyellownailsyndrome
AT haruhitosugiyama effectivenessofclarithromycininpatientswithyellownailsyndrome